Form 4: Clorox Director Russell J. Weiner Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Russell J. Weiner reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.
Summary
- Russell J. Weiner, a director of Clorox, filed a Form 4 with the SEC detailing changes in beneficial ownership.
- On February 9, 2024, Weiner acquired 95.5271 deferred stock units through dividend reinvestment.
- On March 28, 2024, Weiner acquired 171.4454 deferred stock units in lieu of quarterly director's fees.
- These deferred stock units will be settled in Clorox stock upon Weiner's retirement or termination of service as a director.
- Following these transactions, Weiner beneficially owns 12,462.5967 deferred stock units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions reflect standard compensation practices and insider confidence, but do not represent a major shift in ownership or strategy.
Positives
- The acquisition of deferred stock units demonstrates the director's continued investment in the company.
- Dividend reinvestment indicates confidence in the company's future performance.
- Accepting stock units in lieu of fees aligns the director's interests with those of shareholders.
Future Outlook
The deferred stock units will be settled 100% in Clorox stock upon the reporting person's retirement or other termination of service as a Director.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers. These filings help investors understand the buying and selling activity of those with privileged information about the company.
Comparison to Industry Standards
- Director compensation in the form of stock and deferred stock units is a common practice among publicly traded companies, including Clorox's peers such as Procter & Gamble (PG) and Unilever (UL), to align management's interests with those of shareholders.
- Dividend reinvestment programs are also standard, allowing insiders to increase their stake in the company without direct cash outlay, similar to programs offered by companies like Colgate-Palmolive (CL).
- The specific number of deferred stock units granted and the terms of their vesting and settlement are company-specific and depend on the individual's role, compensation package, and company policies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The acquisition of deferred stock units by a director can be viewed positively by shareholders as it aligns management's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 02/09/2024 | Acquisition of 95.5271 deferred stock units through dividend reinvestment. |
| 03/28/2024 | Acquisition of 171.4454 deferred stock units in lieu of quarterly director's fees. |
| 04/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.